Characterization of an evolutionarily distinct bacterial ceramide kinase from Caulobacter crescentus
Journal of Biological Chemistry · 2023
DOI: 10.1016/j.jbc.2023.104894 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2023. Verfasst von Tanisha Dhakephalkar und 4 weiteren Autor:innen. Beteiligte Einrichtung: Biology Department, Rutgers University-Camden, Camden, New Jersey, USA. Hauptthemen laut MEDLINE: Caulobacter crescentus, Ceramides. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIGMS NIH HHS, National Science Foundation.
Abstract (Originalsprache)
A common feature among nearly all gram-negative bacteria is the requirement for lipopolysaccharide (LPS) in the outer leaflet of the outer membrane. LPS provides structural integrity to the bacterial membrane, which aids bacteria in maintaining their shape and acts as a barrier from environmental stress and harmful substances such as detergents and antibiotics. Recent work has demonstrated that Caulobacter crescentus can survive without LPS due to the presence of the anionic sphingolipid ceramide-phosphoglycerate (CPG). Based on genetic evidence, we predicted that protein CpgB functions as a ceramide kinase and performs the first step in generating the phosphoglycerate head group. Here, we characterized the kinase activity of recombinantly expressed CpgB and demonstrated that it can phosphorylate ceramide to form ceramide 1-phosphate. The pH optimum for CpgB was 7.5, and the enzyme required Mg2+ as a cofactor. Mn2+, but no other divalent cations, could substitute for Mg2+. Under these conditions, the enzyme exhibited typical Michaelis-Menten kinetics with respect to NBD C6-ceramide (Km,app = 19.2 ± 5.5 μM; Vmax,app = 2590 ± 230 pmol/min/mg enzyme) and ATP (Km,app = 0.29 ± 0.07 mM; Vmax,app = 10,100 ± 996 pmol/min/mg enzyme). Phylogenetic analysis of CpgB revealed that CpgB belongs to a new class of ceramide kinases, which is distinct from its eukaryotic counterpart; furthermore, the pharmacological inhibitor of human ceramide kinase (NVP-231) had no effect on CpgB. The characterization of a new bacterial ceramide kinase opens avenues for understanding the structure and function of the various microbial phosphorylated sphingolipids.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Biology Department, Rutgers University-Camden, Camden, New Jersey, USA.
- Department of Food Science, Rutgers University, New Brunswick, New Jersey, USA; Rutgers Center for Lipid Research, New Jersey Institute for Food Nutrition and Health, Rutgers University, New Brunswick, New Jersey, USA.
- Department of Biochemistry, Duke University Medical Center, Durham, North Carolina, USA.
- Biology Department, Rutgers University-Camden, Camden, New Jersey, USA; Department of Food Science, Rutgers University, New Brunswick, New Jersey, USA; Rutgers Center for Lipid Research, New Jersey Institute for Food Nu…
Förderung
- NIAID NIH HHS
- NIGMS NIH HHS
- National Science Foundation
- National Institutes of Health
Zitieren
APA
Dhakephalkar, T., Stukey, G. J., Guan, Z., Carman, G. M., & Klein, E. A. (2023). Characterization of an evolutionarily distinct bacterial ceramide kinase from Caulobacter crescentus. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2023.104894
Vancouver
Dhakephalkar T, Stukey GJ, Guan Z, Carman GM, Klein EA. Characterization of an evolutionarily distinct bacterial ceramide kinase from Caulobacter crescentus. Journal of Biological Chemistry. 2023. doi:10.1016/j.jbc.2023.104894
BibTeX
@article{Dhakephalkar2023,
author = {Dhakephalkar, Tanisha and Stukey, Geordan J and Guan, Ziqiang and Carman, George M and Klein, Eric A},
title = {Characterization of an evolutionarily distinct bacterial ceramide kinase from Caulobacter crescentus},
journal = {Journal of Biological Chemistry},
year = {2023},
doi = {10.1016/j.jbc.2023.104894}
}
EUVIMED